No Data
StemRIM to Slash Capital by 106.4 Million Yen, Calls July Shareholder Vote
Japan Stocks Fall as BOJ Warns US Tariffs Could Weigh on Growth
April 4th [Today's Investment Strategy]
[FISCO Selected Stocks] 【Material Stocks】 Onward Holdings <8016> 517 yen (4/3) Clothing manufacturer. Brands include "23区", "組曲", and "iCB" among others. The financial results for the fiscal year ending February 2025 have been announced. The operating profit is 10.1 billion yen (a 9.8% decrease from the previous year). The previous Financial Estimates were 12.5 billion yen (an 11.0% increase). It has been noted that challenges remain in addressing climate change, etc. The operating profit forecast for the fiscal year ending February 2026 is 11.5 billion yen (a 13.3% increase from the previous year). Operating profit for the entire Overseas business.
StemRIM Secures China Patent for Redasemtide Regenerative Drug Candidate
Awareness of a soft trend and risk-averse movements.
[Emerging Markets Individual Stock Global Strategy] Today's emerging markets are expected to have a weak performance. In the U.S. stock market yesterday, the Dow Inc fell significantly by 1,679.39 dollars (-3.98%) to 40,545.93 dollars. The impact of 'mutual tariffs' on the economy and concerns over trade friction weighed on stock prices. Additionally, the ISM Non-Manufacturing Index ETF declined more than expected, further strengthening concerns of entering a recession, which expanded the drop. Today's emerging markets are likely to show a dominant trend of Sell.
Stem Inc, Decorte HD and others.
The patent is registered (in China) for the regenerative induction drug Redasemtide (HMGB1 fragment peptide) for traumatic cartilage defects, osteoarthritis, and osteochondritis dissecans. The capital and business partnership agreement with MIXI, which handles the Decorte HD digital entertainment business, has been dissolved. The stock offering (1.35 million shares of 3,800 shares) and a basic agreement for a capital and business partnership with IBJ has been concluded.